Other OTC - Delayed Quote USD

Can B Corp. (CANB)

0.0345 0.0000 (0.00%)
At close: April 22 at 10:45 AM EDT
Loading Chart for CANB
DELL
  • Previous Close 0.0345
  • Open 0.0294
  • Bid --
  • Ask --
  • Day's Range 0.0294 - 0.0345
  • 52 Week Range 0.0120 - 0.8900
  • Volume 3,641
  • Avg. Volume 349,738
  • Market Cap (intraday) 1.702M
  • Beta (5Y Monthly) 1.59
  • PE Ratio (TTM) --
  • EPS (TTM) -0.7700
  • Earnings Date May 6, 2024 - May 10, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Can B Corp., a health and wellness company, develops, manufactures, and sells hemp derived products in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil brands through medical professionals, website, and vending machines. The company also produces industrial hemp, and processes hemp biomass, isolate, and isomers, such as CBN, CBG, delta-8, and delta-10; and manufactures and sells durable medical equipment. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.

canbcorp.com

12

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CANB

Performance Overview: CANB

Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CANB
27.78%
S&P 500
5.05%

1-Year Return

CANB
95.40%
S&P 500
21.22%

3-Year Return

CANB
99.54%
S&P 500
20.06%

5-Year Return

CANB
99.98%
S&P 500
72.48%

Compare To: CANB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CANB

Valuation Measures

Annual
As of 4/22/2024
  • Market Cap

    1.70M

  • Enterprise Value

    18.71M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.20

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    8.68

  • Enterprise Value/EBITDA

    -3.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -36.43%

  • Return on Equity (ttm)

    -1,148.32%

  • Revenue (ttm)

    2.16M

  • Net Income Avi to Common (ttm)

    -9.74M

  • Diluted EPS (ttm)

    -0.7700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    34.01k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    1.35M

Research Analysis: CANB

Analyst Price Targets

 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: CANB

People Also Watch